» Articles » PMID: 37762843

Are There Any Differences in Clinical and Biochemical Variables Between Bipolar Patients with or Without Lifetime Psychotic Symptoms?

Abstract

Introduction: Psychotic symptoms occur in more than half of patients affected by Bipolar Disorder (BD) and are associated with an unfavorable course of the disorder. The objective of this study is to identify the differences in the clinical and biochemical parameters between bipolar patients with or without psychotic symptoms.

Methods: A total of 665 inpatients were recruited. Demographic, clinical, and biochemical data related to the first day of hospitalization were obtained via a screening of the clinical charts and intranet hospital applications. The two groups identified via the lifetime presence of psychotic symptoms were compared using t tests for quantitative variables and χ tests for qualitative ones; binary logistic regression models were subsequently performed.

Results: Patients with psychotic BD (compared to non-psychotic ones) showed a longer duration of hospitalization ( < 0.001), higher Young Mania Rating Scale scores ( < 0.001), lower Global Assessment of Functioning scores ( = 0.002), a less frequent history of lifetime suicide attempts ( = 0.019), less achievement of remission during the current hospitalization ( = 0.028), and a higher Neutrophile to Lymphocyte Ratio (NLR) ( = 0.006), but lower total cholesterol ( = 0.018) and triglycerides ( = 0.013).

Conclusions: Patients with psychotic BD have a different clinical and biochemical profile compared to their counterparts, characterized by more clinical severity, fewer metabolic alterations, and a higher grade of inflammation. Further multi-center studies have to confirm the results of this present study.

Citing Articles

Gender Differences in Clinical and Biochemical Variables of Patients Affected by Bipolar Disorder.

Piccirilli L, Capuzzi E, Legnani F, Di Paolo M, Pan A, Ceresa A Brain Sci. 2025; 15(2).

PMID: 40002546 PMC: 11853631. DOI: 10.3390/brainsci15020214.

References
1.
Baldessarini R, Tondo L . Suicidal Risks in 12 DSM-5 Psychiatric Disorders. J Affect Disord. 2020; 271:66-73. DOI: 10.1016/j.jad.2020.03.083. View

2.
Wagner C, Musenbichler C, Bohm L, Farber K, Fischer A, von Nippold F . LDL cholesterol relates to depression, its severity, and the prospective course. Prog Neuropsychopharmacol Biol Psychiatry. 2019; 92:405-411. DOI: 10.1016/j.pnpbp.2019.01.010. View

3.
Salvo G, Porceddu G, Albert U, Maina G, Rosso G . Correlates of long duration of untreated illness (DUI) in patients with bipolar disorder: results of an observational study. Ann Gen Psychiatry. 2023; 22(1):12. PMC: 10035162. DOI: 10.1186/s12991-023-00442-5. View

4.
Buoli M, Cesana B, Bolognesi S, Fagiolini A, Albert U, Salvo G . Factors associated with lifetime suicide attempts in bipolar disorder: results from an Italian nationwide study. Eur Arch Psychiatry Clin Neurosci. 2021; 272(3):359-370. PMC: 8938374. DOI: 10.1007/s00406-021-01343-y. View

5.
Piacentino D, Kotzalidis G, Del Casale A, Aromatario M, Pomara C, Girardi P . Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review. Curr Neuropharmacol. 2015; 13(1):101-21. PMC: 4462035. DOI: 10.2174/1570159X13666141210222725. View